HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy

AIDS

Volumn 18, Issue 5, 2004, Pages 719-728

  Hué, Stéphane ^a,b,c   Clewley, Jonathan P ^c   Cane, Patricia A ^a   Pillay, Deenan ^a,b,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Drug resistance; HIV 1 transmission; Phylogenetic analyses; Pol gene

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CODON; CONTROLLED STUDY; DATA BASE; DRUG SELECTIVITY; ENVELOPE GENE; EPIDEMIOLOGICAL DATA; GENE; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC DISTANCE; GENETIC LINKAGE; GENETIC VARIABILITY; GROUP SPECIFIC ANTIGEN GENE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAXIMUM LIKELIHOOD METHOD; NEIGHBOR JOINING METHOD; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE CONSTRUCTION METHOD; PHYLOGENY; PRIORITY JOURNAL; PROTEIN MOTIF; STRUCTURAL GENE; UNITED KINGDOM; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DATABASES, GENETIC; DRUG RESISTANCE, VIRAL; GENES, ENV; GENES, GAG; GENES, POL; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VARIATION (GENETICS);

EID: 2142768288     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200403260-00002     Document Type: Article

References (38)

1. Preston BD, Dougherty JP. Mechanisms of retroviral mutation. Trends Microbiol 1996, 4:16-21.
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
3. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
4. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol 1995, 40:249-259.
5. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002, 296:2354-2360.
6. Novitsky V, Smith UR, Gilbert P, McLane MF, Chigwedere P, Williamson C, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol 2002, 76:5435-5451.
7. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001, 58:19-42.
8. Hanna GJ, D'Aquila RT. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy. Clin Infect Dis 2001, 32:774-782.
9. Hirsch MS, Brun-Vezinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA 2000, 283:2417-2426.
10. Arnold C, Balfe P, Clewley JP. Sequence distances between env genes of HIV-1 from individuals infected from the same source: implications for the investigation of possible transmission events. Virology 1995, 211:198-203.
11. Hayman A, Moss T, Simmons G, Arnold C, Holmes EC, Naylor-Adamson L, et al. Phylogenetic analysis of multiple heterosexual transmission events involving subtype b of HIV type 1. AIDS Res Hum Retroviruses 2001, 17:689-695.
12. Taylor S, Cane P, Hue S, Xu L, Wrin T, Lie Y, et al. Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations. AIDS Res Hum Retroviruses 2003, 19:353-361.
13. Leitner T, Escanilla D, Franzen C, Uhlen M, Albert J. Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc Natl Acad Sci USA 1996, 93: 10864-10869.
14. Ou CY, Ciesielski CA, Myers G, Bandea CI, Luo CC, Korber BT, et al. Molecular epidemiology of HIV transmission in a dental practice. Science 1992, 256:1165-1171.
15. Albert J, Wahlberg J, Leitner T, Escanilla D, Uhlen M. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol 1994, 68:5918-5924.
16. Machuca R, Jorgensen LB, Theilade P, Nielsen C. Molecular investigation of transmission of human immunodeficiency virus type 1 in a criminal case. Clin Diagn Lab Immunol 2001, 8: 884-890.
17. Palmer S, Vuitton D, Gonzales MJ, Bassignot A, Shafer RW. Reverse transcriptase and protease sequence evolution in two HIV-1-infected couples. J Acquir Immune Defic Syndr 2002, 31:285-290.
18. Smith TF, Waterman MS. The continuing case of the Florida dentist. Science 1992, 256:1155-1156.
19. DeBry RW, Abele LG, Weiss SH, Hill MD, Bouzas M, Lorenzo E, et al. Dental HIV transmission? Nature 1993, 361:691.
20. Pasquier C, Millot N, Njouom R, Sandres K, Cazabat M, Puel J, et al. HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001, 94:45-54.
21. Kessler HH, Deuretzbacher D, Stelzl E, Daghofer E, Santner BI, Marth E. Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory. Clin Diagn Lab Immunol 2001, 8:1018-1020.
22. Yahi N, Fantini J, Tourres C, Tivoli N, Koch N, Tamalet C. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. J Infect Dis 2001, 183: 1311-1317.
23. Rodriguez F, Oliver JL, Marin A, Medina JR. The general stochastic model of nucleotide substitution. J Theor Biol 1990, 142:485-501.
24. Posada D, Crandall KA. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14:817-818.
25. Swofford DL. PAUP 4.0: Phylogenetic Analysis Using Parsimony (And Other Methods). Sunderland, MA: Sinaur Associates; 2001.
26. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997, 25:4876-4882.
27. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Series 2000, 41:95-98.
28. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
29. Felsenstein J. Maximum-likelihood estimation of evolutionary trees from continuous characters. Am J Hum Genet 1973, 25:471-492.
30. Hasegawa M, Kishino H, Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985, 22:160-174.
31. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980, 16:111-120.
32. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985, 39:783-791.
33. Shafer RW, Dupnik K, Winters MA, Eschleman SH. A guide to HIV-1 reverse transcriptase and protease sequencing for drug resistance studies. In: HIV Sequence Compendium. Edited by Sodroski J. Los Alamos: Los Alamos National Laboratory; 2000.
34. D'Aquila RT, Schapiro JM, Brun-Vezinet F, Clotet B, Conway B, Demeter LM, et al. Drug resistance mutations in HIV-1. Top HIV Med 2003, 11:92-96.
35. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000, 288:1789-1796.
36. Li WH, Tanimura M, Sharp PM. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol Biol Evol 1988, 5:313-330.
37. Pillay D, Taylor S, Richman DD. Incidence and impact of resistance against approved antiretroviral drugs. Rev Med Virol 2000, 10:231-253.
38. Ammaranond P, Cunningham P, Oelrichs R, Suzuki K, Harris C, Leas L, et al. Rates of transmission of antiretroviral drug resistant strains of HIV-1. J Clin Virol 2003, 26:153-161.